GILEAD COULD GET FDA APPROVAL FOR USE OF REMDESIVIR DESPITE MIXED TRIAL RESULTS

Highlights –

• Gilead could get FDA approval for use of Remdesivir despite mixed trail results.
• The FDA had approved in May for sale of the drug to be used on an emergency basis for patients with severe COVID-19.
• The company had published data on Friday with regards to the drug; a 5 day course and a 10 day course.
• Journal of the American Medical Association had published ....
  Click here to read more

  ---

  Tags : U.S.A, GILEAD SCIENCES, REMDESIVIR, FOOD AND DRUG ADMINISTRATION, FDA APPROVAL, TREAT COVID-19 PATIENTS, COVID-19,

  ---

  SHARE THIS ARTICLE